PAGP Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Plains GP Holdings LP (PAGP) does not present a compelling buy opportunity for a beginner, long-term investor at this time. The stock's technical indicators are mixed, with a negative MACD and neutral RSI, while the pre-market price is down 1.19%. Options data suggests bearish sentiment with a high put-call volume ratio. Additionally, the company's recent financial performance shows significant declines in revenue, net income, and EPS, which raises concerns about its growth trajectory. Analysts' ratings are mixed, with some positive outlooks but also underweight and underperform ratings. Given these factors, it is recommended to hold off on investing in PAGP for now.
The MACD histogram is negative (-0.139) and expanding downward, indicating bearish momentum. RSI is neutral at 41.705, and moving averages are bullish (SMA_5 > SMA_20 > SMA_200). Key support is at 23.378, and resistance is at 24.596. Pre-market price is down 1.19%, suggesting short-term weakness.
Analysts highlight the company's strong position in the Permian Basin and potential for long-term growth due to structurally higher crude prices. The company also announced stable cash distributions for Q1 2026.
Recent financial performance is weak, with significant YoY declines in revenue (-12.22%), net income (-663.64%), and EPS (-550%). Pre-market price is down 1.19%, and options data shows bearish sentiment with a high put-call volume ratio (3.57).
In Q4 2025, revenue dropped by 12.22% YoY to $10.56 billion. Net income plummeted by 663.64% YoY to $62 million, and EPS fell by 550% YoY to 0.27. However, gross margin improved by 14.45% YoY to 6.97.
Analysts' ratings are mixed: Barclays maintains an Underweight rating with a $21 target, while Truist and Stifel have Buy ratings with price targets of $23 and $25, respectively. Morgan Stanley and Citi have Neutral/Equal Weight ratings with targets of $24 and $20. BofA downgraded the stock to Underperform with a $19 target.
